Jump to a section
Daily Wolverine Stack dosage
500 mcg BPC-157 + 500 mcg TB-500 once daily equals 1,000 mcg, or 1 mg, of total blend per day. A published shoulder-recovery account used that amount for four weeks. [1]
One daily administration in the cited account.
- BPC-157
- 500 mcg
- TB-500
- 500 mcg
1 mg daily × 7 days.
- BPC-157 per week
- 3.5 mg
- TB-500 per week
- 3.5 mg
An attributed use example, not a proven treatment dose. The supplied vial has the same 1:1 weight ratio; that does not establish the same clinical outcome.
A separate physician-published 1:1 protocol lists 300 mcg of each ingredient once daily in week one, then 600 mcg of each once daily. Those are 600 mcg and 1,200 mcg total blend, respectively. Its standard-dose row specifies four to six weeks. [2]
A fixed blend keeps both ingredients equal
Every 1 mg taken from the 10 mg + 10 mg vial contains 0.5 mg of each peptide. You cannot increase one ingredient without increasing the other. Separate-vial protocols can use different schedules: one clinic guide describes daily BPC-157 and twice-weekly TB-500. A 1:1 vial cannot reproduce that pattern. [3]
500 mcg total and 500 mcg of each
- 500 mcg total blend
- 250 mcg BPC-157 + 250 mcg TB-500
- 500 mcg of each
- 1,000 mcg total blend
- 1,000 mcg total blend
- 1 mg total, not 1 mg of each
“Total blend” and “of each” change the amount by a factor of two. A bare “500 mcg” is incomplete unless the ingredient breakdown is clear.
1:1 and 2:1 blends have different ingredient amounts
The supplied vial contains 10 mg BPC-157 + 10 mg TB-500: a 1:1 ratio by mass. A different product containing 10 mg BPC-157 + 5 mg TB-500 would be 2:1 and contain 15 mg total. In that 2:1 example, a 1,500 mcg total portion contains 1,000 mcg BPC-157 and 500 mcg TB-500. Dividing the amount in half only works for a 1:1 blend. [4]
The 2:1 example explains label arithmetic; it is not a second supplied product or a way to change the ratio by adding water.
Wolverine Stack dosage and body weight
The cited amounts are fixed micrograms, not micrograms per kilogram. The 1 mg daily account and the clinic’s 300/600 mcg-per-ingredient examples do not supply a tested adjustment for a lighter or heavier adult. Multiplying a fixed amount by body weight changes the instruction. Neither account establishes an effective weight-based Wolverine Stack formula. [1] [2]
Reconstituting a 20 mg Wolverine Stack vial
20 mg in a final solution volume of 2 mL gives 10 mg/mL of total blend: 5 mg/mL BPC-157 and 5 mg/mL TB-500. Adding more liquid lowers the concentration; it does not add peptide.
Match the 20 mg vial
Check 10 mg BPC-157 + 10 mg TB-500 and lot PL-2609-011 against the redacted COA. [4]
Confirm the liquid
Use the compatible diluent and mixing method supplied for the product. The COA itself does not provide a reconstitution recipe.
Keep equipment clean
Use fresh sterile transfer equipment and a clean preparation area. Never reuse a needle or syringe. [5]
Measure final volume
The example uses 2 mL after preparation. Enter the actual final volume in the calculator.
Record both strengths
At 2 mL: 10 mg/mL total, comprising 5 mg/mL BPC-157 and 5 mg/mL TB-500.
Use the correct storage limit
The COA specifies −20°C, dry and dark for the powder. Obtain separate storage and use limits for the prepared liquid. [4]
2 mL is a calculation example, not a verified preparation instruction. The supplied report covers research powder; it does not certify a home-prepared injection.
10 mg total is different from 10 mg + 10 mg
A 10 mg total 1:1 vial would contain 5 mg of each peptide. The supplied 10 mg + 10 mg vial contains 20 mg combined. Using 10 mg as its calculator input would halve the entered concentration and double the calculated volume for the same target amount.
General subcutaneous injection sites
Subcutaneous injections go into fatty tissue under the skin. General medication sites are the abdomen, outer upper thighs, and the side or back of the upper arms. Rotate spots and avoid damaged skin. [6]
Abdominal fatty tissue
Below the ribs and above the hips. Stay at least 2 inches (about 5 cm) from the belly button.
Outer upper thighs
Use the outer upper thigh and healthy skin.
Side / back of upper arms
Keep 3 inches (7.6 cm) clear of the shoulder and elbow. Ask for a technique demonstration.
A joint, tendon or ligament is not a subcutaneous site. Have the clinician demonstrate the prescribed route and technique. Clinical joint-injection results →
Morning or evening, food and time off
Keep the timing consistent
A morning dose has not been shown to outperform an evening dose. The cited protocols do not provide a controlled comparison.
No proven fasting advantage
The clinical-practice guide allows subcutaneous dosing with or without meals. It does not establish better absorption on an empty stomach. [3]
At least four weeks off in one clinic protocol
One clinic guide describes at least four weeks off. That is a practice example, not a tested interval that guarantees a safe restart. [3]
Splitting an amount changes the schedule, not the daily total. A 500 mcg total-blend amount twice daily still adds up to 1 mg a day. Taking 500 mcg of each ingredient twice daily adds up to 2 mg a day.
Wolverine Stack half-life and injection frequency
The two ingredients do not have one established “Wolverine Stack half-life.” The BPC-157 figures of 15.2 minutes in rats and 5.27 minutes in dogs measured a single intravenous dose, not a subcutaneous Wolverine Stack blend. [8]
FDA’s 2026 review found no human BPC-157 pharmacokinetic data after subcutaneous administration. Those animal numbers cannot establish a human dosing interval or prove that splitting a blend works better. The time a peptide stays measurable in blood also differs from how long its effects on tissue may last. [9]
Wolverine Stack vial calculator
Enter the vial's total blend mass. For the supplied powder vial, use 20 mg, not 10 mg. With 2 mL final solution and a 1,000 mcg total target, the result is 0.1 mL, or 10 units on a U-100 syringe.
Concentration & draw volume
Enter the total blend in the vial, final solution volume and target total amount. The ingredient split updates for this 1:1 blend.
Loaded with 20 mg vial / 2 mL solution. Arithmetic example.
10 mg BPC-157 + 10 mg TB-500 = 20 mg total.
Use the final solution volume after mixing.
Target = both ingredients combined. 1,000 mcg total contains 500 mcg of each.
Use the final solution volume. The example treats 2 mL of BAC water as approximately 2 mL of final solution; follow the product’s actual preparation instructions.
Calculation ready.
U-100 units are volume markings, not peptide activity units or pen clicks. Portion counts are quantity calculations and exclude waste, priming and discard limits.
At this concentration, 1 U-100 unit is 0.01 mL and contains 100 mcg of blend: 50 mcg BPC-157 + 50 mcg TB-500. The U-100 marking measures volume. It is not an insulin dose or a peptide dose by itself.
20 mg vial: mL and U-100 units
| Final volume | Total concentration | Volume for 1 mg | U-100 scale |
|---|---|---|---|
| 1 mL | 20 mg/mL | 0.05 mL | 5 units |
| 2 mL | 10 mg/mL | 0.10 mL | 10 units |
| 3 mL | 6.67 mg/mL | 0.15 mL | 15 units |
Calculation scenarios, not mixing instructions. Every row delivers the same label-based 500 mcg BPC-157 + 500 mcg TB-500. The 3 mL concentration is rounded for display; the volume uses the exact 20 ÷ 3 value.
The same “10 units” does not mean the same amount across these solutions. It represents 2 mg total in the 1 mL scenario, 1 mg in the 2 mL scenario, and about 667 mcg in the 3 mL scenario. A pen click is a different device measurement.
Daily and weekly totals
| Amount each time | Times per day | Total blend per day | Each ingredient per day | Total blend per week |
|---|---|---|---|---|
| 1,000 mcg total | 1 | 1 mg | 500 mcg | 7 mg |
| 500 mcg total | 2 | 1 mg | 500 mcg | 7 mg |
The second row is a calculation comparison, not evidence that twice-daily dosing works better. Seven-day totals assume administration every day; a five-day schedule would use 5 mg of blend per week at the same daily amount.
Adding BPC-157 or TB-500 separately
A 1 mg Wolverine Stack amount already includes 500 mcg BPC-157 and 500 mcg TB-500. Adding a separate 500 mcg BPC-157 amount changes the combined intake to 1,000 mcg BPC-157 + 500 mcg TB-500. Include ingredients from every vial or pen when checking the total.
Separate schedules cannot be copied into a fixed blend
A six-week account used 250 mcg BPC-157 twice daily and 1,500 mcg TB-500 three times weekly. That adds up to 3.5 mg BPC-157 and 4.5 mg TB-500 per week. The writer described no improvement in the targeted elbow, wrist and shoulder symptoms. [10]
A 1:1 blend alone cannot reproduce those unequal totals. Dividing 4.5 mg by seven only gives a daily average; it does not make three weekly administrations equivalent to seven. Changing the volume drawn from a premix changes both ingredient amounts together. Six-week result and context →
Wolverine Stack cycle length
Four weeks is the duration in the cited 1 mg daily shoulder account. A separate physician-published blend schedule lists a lower starting week and a four- to six-week standard-dose phase. These are specific examples; they do not show that a longer cycle produces more repair. [1] [2]
Wolverine Stack pen amounts
The prefilled pen needs its own confirmed strength and delivery specification. The product title gives 20 mg combined in 3 mL, but its specifications table gives 20 mg of each ingredient. Those descriptions disagree. [7]
Until the cartridge label resolves that difference, a reliable pen concentration or number of portions cannot be calculated. A click count also requires the delivered volume per click for the exact device. The vial calculator's U-100 result is not a pen setting.
The redacted powder-lot COA accompanies both product cards. It does not measure the pen's final fill volume, strength per click or liquid stability. Pen specifications and COA →
Total milligrams and vials for a course
At the 1 mg daily example, a 20 mg vial contains 20 mathematical portions. A four-week course uses 28 mg of blend, comprising 14 mg BPC-157 and 14 mg TB-500.
| Duration | Total blend | BPC-157 | TB-500 | 20 mg vials, rounded up |
|---|---|---|---|---|
| 4 weeks · 28 days | 28 mg | 14 mg | 14 mg | 2 |
| 6 weeks · 42 days | 42 mg | 21 mg | 21 mg | 3 |
| 8 weeks · 56 days | 56 mg | 28 mg | 28 mg | 3 |
Calculation: daily blend mg × days ÷ 20 mg per vial, rounded up to whole vials. These figures exclude preparation losses, discarded material and post-mixing use limits. They calculate quantity; they do not establish how long an opened vial remains usable.
Questions & answers.
Does 1 mg Wolverine Stack mean 1 mg of each peptide?
No. In the supplied 1:1 blend, 1 mg total means 0.5 mg BPC-157 plus 0.5 mg TB-500. Taking 1 mg of each would mean 2 mg total.
How much liquid corresponds to 1,000 mcg from a 20 mg vial?
With a final solution volume of 2 mL, the concentration is 10 mg/mL. A 1,000 mcg total amount is 0.1 mL, which is 10 units on a U-100 scale. A different final volume changes that result.
Can I reuse the units from another Wolverine Stack dosing chart?
Only if the total concentration and syringe scale match. A clinic example using 6 mg/mL is different from a 20 mg vial prepared to 2 mL, which is 10 mg/mL.
Does twice-daily dosing double the daily amount?
It does if you repeat the full once-daily amount. Two 500 mcg total-blend amounts add up to 1 mg per day; two 1,000 mcg amounts add up to 2 mg.
Can a 1:1 blend follow a daily BPC-157 and twice-weekly TB-500 schedule?
A fixed blend delivers both peptides every time. Separate ingredients are needed to control their frequencies and amounts independently.
How many 20 mg vials equal four weeks at 1 mg per day?
Twenty-eight days use 28 mg total, so two 20 mg vials provide enough label mass mathematically. Actual usable portions also depend on preparation losses and the product’s use limit.
Does adding more water change the Wolverine Stack ratio?
No. The supplied 20 mg vial stays 10 mg BPC-157 plus 10 mg TB-500, a 1:1 ratio. More liquid changes the concentration and the volume needed for a given total amount; it does not change the ingredient split.
Is Wolverine Stack dosage calculated by body weight?
The cited daily examples use fixed amounts, not amounts per kilogram. They do not establish a tested body-weight formula. A volume calculator can convert an entered amount into mL and U-100 units; it cannot choose an effective amount from body weight.
Sources & batch documents10 references · expand to read
- u/604Hustle: 500 mcg BPC-157 + 500 mcg TB-500 daily for four weeks — firsthand shoulder account ↗
- Dr. Jason Wright: published 1:1 Wolverine blend protocol — clinical-practice example ↗
- BHRC Clinical Team: separate BPC-157/TB-500 schedules, timing and course examples ↗
- Redacted supplied Wolverine powder-lot COA — PL-2609-011, certificate PL-26-00011 ↗
- CDC: aseptic preparation and preventing unsafe injection practices ↗
- MedlinePlus: general subcutaneous medication sites, skin condition and site rotation ↗
- Wolverine vial and pen: supplied specifications, strength discrepancy and redacted COA ↗
- He et al. (2022): original BPC-157 pharmacokinetic measurements in rats and beagle dogs ↗
- FDA (2026): scientific review, including the absence of human subcutaneous BPC-157 pharmacokinetic data ↗
- u/Main-Pea-912: six-week account with separately scheduled BPC-157 and TB-500 and no improvement ↗